本页面由Tiger Trade Technology Pte. Ltd.提供服务

NovoCure Limited

12.62
+0.45003.70%
盘后12.620.00000.00%19:09 EDT
成交量:160.32万
成交额:2,004.60万
市值:14.39亿
市盈率:-10.33
高:12.73
开:12.24
低:12.13
收:12.17
52周最高:20.06
52周最低:9.82
股本:1.14亿
流通股本:9,414.79万
量比:1.44
换手率:1.70%
股息:- -
股息率:- -
每股收益(TTM):-1.2221
每股收益(LYR):-1.2221
净资产收益率:-38.89%
总资产收益率:-9.06%
市净率:4.23
市盈率(LYR):-10.33

数据加载中...

2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/09

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report